Life sciences specialist Abingworth Management has appointed Michelle Doig to advise Abingworth on funding and refinancing its portfolio companies. She is based at the company’s headquarters in London, UK.
Doig was formerly director corporate finance and advisory at Bioscience Managers where she advised UK and European life science companies on strategic, M&A and financial transactions. Prior to joining BML, Doig worked with UK and European life sciences companies at Lehman Brothers International, London.
Previously she was part of the JP Morgan biotechnology team in New York and the Morgan Stanley healthcare team in Toronto and New York.
Stephen Bunting, managing director at Abingworth, said: “The process of re-financing companies is a highly specialised part of the venture investment business. We think Michelle has an excellent understanding of this area, knows all the key players on both sides of the Atlantic and will improve Abingworth’s efficiency in completing and closing financings.”